Esperion Therapeutics

(NASDAQ: ESPR)
Healthcare  |  Biotechnology
40.47 0.56 1.4%
Stock Price | Nov. 15, 2019, 4 p.m.
1 Follower
Bid: 0.0
Ask: 0.0
Prev. Close: 39.91
52 Week Low: 33.13
52 Week High: 58.5
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm has Business of researching, developing and commercializing therapies for the treatment of patients with the elevated LDL-C operating segment.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 09/07/2016

3 years ago

Premium Stock Watchlist 11/04/2015

4 years ago

Premium Stock Watchlist 10/29/2015

4 years ago
4 years ago

Free June 2015 Trade Recommendations

4 years ago

Free 5 Biotech Stocks On Deck With The FDA

4 years ago

Premium Stock Watchlist 4/15/2015

4 years ago